Evidence map›Paper›PMID 26171028›Full record

ArticleOncology letters2015

Atypical amplification of chromosome region 22q12 in melanoma: A case report.

Giuseppina Liguori, Monica Cantile, Francesca Collina, Laura Marra, Anna DE Chiara, Renato Franco, Michele Caraglia, Gerardo Botti, Mirella D'Andrea, Giovanni Francesco Nicoletti

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Giuseppina LiguoriPathology Unit, National Cancer Institute IRCCS 'Fondazione G. Pascale', Naples 80131, Italy.
Monica CantilePathology Unit, National Cancer Institute IRCCS 'Fondazione G. Pascale', Naples 80131, Italy.
Francesca CollinaPathology Unit, National Cancer Institute IRCCS 'Fondazione G. Pascale', Naples 80131, Italy.
Laura MarraPathology Unit, National Cancer Institute IRCCS 'Fondazione G. Pascale', Naples 80131, Italy.
Anna DE ChiaraPathology Unit, National Cancer Institute IRCCS 'Fondazione G. Pascale', Naples 80131, Italy.
Renato FrancoPathology Unit, National Cancer Institute IRCCS 'Fondazione G. Pascale', Naples 80131, Italy.
Michele CaragliaDepartment of Biochemistry, Biophysics and General Pathology, Second University of Naples, Naples 80138, Italy.
Gerardo BottiPathology Unit, National Cancer Institute IRCCS 'Fondazione G. Pascale', Naples 80131, Italy.
Mirella D'AndreaDepartment of Medical-Surgical and Dental Specialities, Second University of Naples, Naples 80138, Italy.
Giovanni Francesco NicolettiDepartment of Medical-Surgical and Dental Specialities, Second University of Naples, Naples 80138, Italy.
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" · ITUniversity of Naples Federico II · ITUniversity of Campania "Luigi Vanvitelli" · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Morphological, ultrastructural and immunohistochemical characteristics of clear cell sarcoma (CCS) of the soft tissue frequently overlap with those of malignant melanoma. Thus, the differential diagnosis between the two lesions represents an important diagnostic dilemma. However, a number of genetic factors can be used to differentiate the two tumors; in particular, the t(12;22)(q13;q12) chromosomal translocation is typical of CCS, resulting in fusion of the

Indexed as

chromosomal translocationclear cell sarcomadifferential diagnosisEWSR1 genefluorescence in situ hybridization

Identifiers

PMID26171028
PMCPMC4487132
OpenAlexW2133640610

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.